Video

How New Regulatory Requirements Have Affected Controlled Dangerous Substance Dispensing

Karen Ryle, MS, RPh, associate chief of pharmacy at Massachusetts General Hospital, discusses how new regulatory requirements have affected controlled dangerous substance dispensing.

Karen Ryle, MS, RPh, associate chief of pharmacy at Massachusetts General Hospital, discusses how new regulatory requirements have affected controlled dangerous substance dispensing.

This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.

Related Videos
Abstract DNA molecule helix inside red blood drop
Related Content
Selection of healthy unsaturated fats, omega 3 - fish, avocado, olives, nuts and seeds - Image credit: anaumenko | stock.adobe.com
March 11th 2025

Ongoing Clinical Trial Compares Omega-3 Types for Dementia Risk Reduction

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Blood pressure medication -- Image credit: asadykov | stock.adobe.com
March 11th 2025

Algorithmic Identification Intervention Increased Adherence to BP Medications in Patients With Hypertension

Gillian McGovern, Associate Editor
Pharmacy Focus: GLP-1 Medications and Pharmacists' Role in Counseling Patients
January 31st 2025

Pharmacy Focus: GLP-1 Medications and Pharmacists' Role in Counseling Patients

Luke Halpern, Assistant Editor
Anatomy of Human Heart on medical background. 3d render - Image credit: ckybe | stock.adobe.com
March 10th 2025

Pharmacists Play an Essential Role in Optimizing Vutrisiran Therapy for ATTR-CM

Kennedy Ferruggia, Assistant Editor
Coronavirus prevention medical surgical masks and hand sanitizer gel bottle dispenser for Covid-19 corona virus protection. Panoramic of PPE - Image credit: Maridav | stock.adobe.com
March 10th 2025

Has It Really Been 5 Years? What’s Changed and What Hasn’t Following the COVID-19 Pandemic

Troy Trygstad, PharmD, PhD, MBA, Pharmacy Times Editor in Chief